Women | Men | p Value for sex interaction | |||
Systolic blood pressure | |||||
HR* (95% CI) | p value | HR* (95% CI) | p value | ||
All-cause mortality | 1.25 (1.13 to 1.39) | <0.001 | 1.18 (1.10 to 1.27) | <0.001 | 0.57 |
CVD mortality | 1.45 (1.25 to 1.68) | <0.001 | 1.38 (1.26 to 1.51) | <0.001 | 0.97 |
CHD mortality | 1.09 (0.86 to 1.38) | 0.47 | 1.34 (1.20 to 1.51) | <0.001 | 0.06 |
Stroke mortality | 2.17 (1.70 to 2.75) | <0.001 | 1.69 (1.37 to 2.09) | <0.001 | 0.18 |
Cancer mortality | 1.03 (0.84 to 1.26) | 0.80 | 0.98 (0.85 to 1.14) | 0.80 | 0.67 |
Respiratory mortality | 1.05 (0.77 to 1.43) | 0.77 | 1.02 (0.83 to 1.26) | 0.83 | 0.97 |
Total cholesterol | |||||
HR† (95% CI) | p value | HR† (95% CI) | p value | ||
All-cause mortality | 1.22 (1.08 to 1.37) | <0.001 | 0.98 (0.91 to 1.06) | 0.68 | 0.007 |
CVD mortality | 1.39 (1.16 to 1.66) | 0.001 | 1.09 (0.98 to 1.21) | 0.11 | 0.05 |
CHD mortality | 1.40 (1.09 to 1.80) | 0.008 | 1.10 (0.96 to 1.25) | 0.17 | 0.14 |
Stroke mortality | 1.53 (1.11 to 2.11) | 0.01 | 1.15 (0.89 to 1.49) | 0.28 | 0.21 |
Cancer mortality | 1.10 (0.88 to 1.37) | 0.41 | 0.86 (0.74 to 0.99) | 0.04 | 0.06 |
Respiratory mortality | 1.20 (0.83 to 1.73) | 0.34 | 0.91 (0.75 to 1.10) | 0.33 | 0.25 |
2-hour glucose¶ | |||||
HR‡ (95% CI) | p value | HR‡ (95% CI) | p value | ||
All-cause mortality | 1.06 (0.96 to 1.17) | 0.25 | 1.15 (1.07 to 1.23) | <0.001 | 0.17 |
CVD mortality | 1.10 (0.95 to 1.27) | 0.20 | 1.21 (1.10 to 1.33) | <0.001 | 0.23 |
CHD mortality | 1.05 (0.85 to 1.30) | 0.66 | 1.25 (1.12 to 1.40) | <0.001 | 0.12 |
Stroke mortality | 1.25 (0.97 to 1.61) | 0.08 | 1.06 (0.83 to 1.35) | 0.65 | 0.38 |
Cancer mortality | 1.03 (0.86 to 1.25) | 0.73 | 1.11 (0.97 to 1.27) | 0.13 | 0.94 |
Respiratory mortality | 1.11 (0.85 to 1.45) | 0.46 | 1.21 (1.00 to 1.47) | 0.05 | 0.55 |
*Hazard ratio associated with a 1 SD increase in systolic BP (20.4 mm Hg women; 21.4 mm Hg men).
†Hazard ratio associated with a 1 SD increase in cholesterol (1.14 mm/l women; 1.16 mm/l men).
‡Hazard ratio associated with a 1 SD increase in 2-hour glucose (0.68 mm/l women; 0.87 mm/l men).
¶2-hour glucose adjusted for time since glucose load (see statistical methods).
CHD, coronary heart disease; CVD, cardiovascular disease.